Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Ligand and SQ Innovation announced a long-term, exclusive commercial license and supply agreements for use of Ligand’s Captisol® technology in the formulation of high-concentration furosemide.
read more
Onyx Scientific has made a strategic investment to position the company for a commercial API license.
read more
Anixa Biosciences has established a strategic alliance and license agreement with Cleveland Clinic for breast cancer vaccine technology.
read more
STA Pharmaceutical announced its ASU in Shanghai and API process R&D and manufacturing facility in Changzhou, have successfully passed two inspections from the FDA.
read more
Samsung Bioepis announced the FDA has approved HADLIMA™ (adalimumab-bwwd), a biosimilar referencing HUMIRA® (adalimumab).
read more
Jubilant Cadista Pharmaceuticals is voluntarily recalling one lot of Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/ 0.02mg, 28x3 Blister Pack/Carton to the consumer level.
read more
Starting in July, the commercial brand for Eurofins Alphora will be Eurofins CDMO, falling under the CDMO umbrella in conjunction with Eurofins Amatsigroup.
read more
Novadoz, the U.S based sales & marketing affiliate for MSN Labs, based in Hyderabad India, has received FDA approval for their generic version of Pregabalin capsules.
read more
Olon S.p.A. announced the start of the construction of a new GMP manufacturing facility at its microbial CDMO facility located in Capua, Italy.
read more
Thursday, August 29, 2019
Ajinomoto Bio-Pharma Services announced its intention to purchase the remaining 50 percent ownership interest in its Visakhapatnam, India joint venture, Granules OmniChem.
read more
Thursday, September 12, 2019
Zhejiang Jiuzhou has entered into a contractual commitment for the purchase of SNPT, an API manufacturing facility in Suzhou, China.
read more
Friday, September 13, 2019
Meitheal announced the launch of the Company’s eight presentations of heparin sodium injection, USP in the US.
read more
Monday, September 16, 2019
Mallinckrodt has entered into a definitive agreement to sell its wholly owned subsidiary BioVectra to an affiliate of H.I.G. Capital for approximately $250 million.
read more
Wednesday, September 18, 2019
Darmerica is voluntarily recalling two lots, DR4654A and DL4654A, of Quinacrine Dihydrochloride, bulk API powder packaged in Amber HDPE Bottles to the consumer level.
read more
Tuesday, September 24, 2019
Bayer, Brigham and Women's Hospital, and Massachusetts General Hospital announced the launch of a joint lab to research new drug candidates to treat chronic lung diseases.
read more